[HTML][HTML] The administration of methotrexate in patients with Still's disease,“real-life” findings from AIDA Network Still Disease Registry

P Ruscitti, J Sota, A Vitale, G Lopalco, F Iannone… - Seminars in arthritis and …, 2023 - Elsevier
Objectives To describe clinical characteristics of patients with Still's disease treated with
methotrexate (MTX) and to assess drug effectiveness evaluating change in disease activity …

The administration of methotrexate in patients with Still's disease,"" real-life"" findings from AIDA Network Still Disease Registry

P RUSCITTI, J SOTA, A VITALE… - Seminars in Arthritis …, 2023 - observatorio.fm.usp.br
Objectives: To describe clinical characteristics of patients with Still's disease treated with
methotrexate (MTX) and to assess drug effectiveness evaluating change in disease activity …

The administration of methotrexate in patients with Still's disease," real-life" findings from AIDA Network Still Disease Registry

P Ruscitti, J Sota, A Vitale, G Lopalco… - … IN ARTHRITIS AND …, 2023 - iris.unito.it
Objectives: To describe clinical characteristics of patients with Still's disease treated with
methotrexate (MTX) and to assess drug effectiveness evaluating change in disease activity …

The administration of methotrexate in patients with Still's disease," real-life" findings from AIDA Network Still Disease Registry

P Ruscitti, J Sota, A Vitale, G Lopalco… - Seminars in Arthritis …, 2023 - publicum.umed.lodz.pl
Objectives: To describe clinical characteristics of patients with Still's disease treated with
methotrexate (MTX) and to assess drug effectiveness evaluating change in disease activity …

The administration of methotrexate in patients with Still's disease

P Ruscitti, J Sota, A Vitale, G Lopalco… - Seminars in arthritis …, 2023 - avesis.marmara.edu.tr
Objectives: To describe clinical characteristics of patients with Still's disease treated with
methotrexate (MTX) and to assess drug effectiveness evaluating change in disease activity …

The administration of methotrexate in patients with Still's disease,“real-life” findings from AIDA Network Still Disease Registry

P Ruscitti, J Sota, A Vitale, G Lopalco… - … IN ARTHRITIS AND …, 2023 - iris.unina.it
Objectives: To describe clinical characteristics of patients with Still's disease treated with
methotrexate (MTX) and to assess drug effectiveness evaluating change in disease activity …

The administration of methotrexate in patients with Still's disease," real-life" findings from AIDA Network Still Disease Registry

P Ruscitti, J Sota, A Vitale, G Lopalco… - … in arthritis and …, 2023 - repository.uantwerpen.be
Objectives: To describe clinical characteristics of patients with Still's disease treated with
methotrexate (MTX) and to assess drug effectiveness evaluating change in disease activity …

The administration of methotrexate in patients with Still's disease," real-life" findings from AIDA Network Still Disease Registry

P Ruscitti, J Sota, A Vitale, G Lopalco… - … IN ARTHRITIS AND …, 2023 - iris.unicampania.it
Objectives: To describe clinical characteristics of patients with Still's disease treated with
methotrexate (MTX) and to assess drug effectiveness evaluating change in disease activity …

The administration of methotrexate in patients with Still's disease,“real-life” findings from AIDA Network Still Disease Registry

P Ruscitti, J Sota, A Vitale, G Lopalco… - … IN ARTHRITIS AND …, 2023 - publicatt.unicatt.it
Objectives: To describe clinical characteristics of patients with Still's disease treated with
methotrexate (MTX) and to assess drug effectiveness evaluating change in disease activity …

The administration of methotrexate in patients with Still's disease," real-life" findings from AIDA Network Still Disease Registry

P Ruscitti, J Sota, A Vitale, G Lopalco… - … IN ARTHRITIS AND …, 2023 - iris.unipa.it
Objectives: To describe clinical characteristics of patients with Still's disease treated with
methotrexate (MTX) and to assess drug effectiveness evaluating change in disease activity …